Osteoporosis en el varón

Moro-Álvarez, M.J.; Cabrera, José Antonio Blázquez

doi:10.1016/j.rce.2009.11.023

Cited by 11 publications

(2 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For osteoporosis in men, there are only a few limited therapy options like bisphosphonate treatment [1, 14]. In prostate hyperplasia or carcinoma after hormone ablation therapy, the treatment of the hypogonadism-induced osteoporosis is more complicated, because the hormone replacement therapy in such conditions is contra-productive or contraindicated.…”

Section: Discussionmentioning

confidence: 99%

Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat

et al. 2011

View full text Add to dashboard Cite

PurposeManagement of hypogonadism-induced osteoporosis in elderly men is still a challenge. We investigated the short-term effects of parathyroid hormone (PTH) treatments on strength, micro-architecture, and mineral density of trochanteric region of orchiectomized rat femur.MethodsEight-month-old male Sprague–Dawley rats (n = 44) were divided into two groups: (1) orchiectomized (ORX) and (2) sham group. Twelve weeks after orchiectomy, half of the orchiectomized animals were treated with daily subcutaneously injected PTH (0.040 mg/kg/BW) (ORX-PTH) for 5 weeks. The other half remained untreated (ORX). The sham-operated group was divided and treated in the same way (sham, sham-PTH). After 5 weeks, both femurs were excised for biomechanical and histomorphometric analysis, trabecular measurements, mineral content assessment, and immunofluorescence analysis.ResultsThe femoral trochanteric strength after PTH treatment was enhanced in the breaking test (ORX-Fmax = 158.7 N vs. ORX + PTH-Fmax = 202 N). Stiffness of treated ORX animals reached nearly the levels observed in untreated sham rats. PTH therapy improved the trabecular connectivity, width, and area (ORX-Tb.Ar = 47.79% vs. ORX + PTH-Tb.Ar = 68.47%, P < 0.05) in the proximal femur. The treated rats showed significantly improved mineral content in ashed femurs (ORX-mineral content = 43.73% vs. ORX + PTH-mineral content = 49.49%) when compared to the untreated animals. A comparison of widths of fluorescence bands in cortical bone of the subtrochanteric cross-sections showed a significant increase in oppositions after the PTH therapy.ConclusionsOur finding supports the hypothesis that PTH therapy seems to be a rational therapy in patients with hypogonadism induced bone loss and improves the bone strength of trochanteric region of rat femur.

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat

et al. 2011

View full text Add to dashboard Cite

show abstract

“…However, male osteoporosis is currently underestimated [5]. The usual treatment for this disease can be done with different classes of drugs, among them, the bisphosphonates.…”

Section: Discussionmentioning

confidence: 99%